MATERIAL SAFETY DATA SHEET
TRANSMIX
VALERO MARKETING & SUPPLY COMPANY
and Affiliates
P.O. Box 696000
San Antonio, TX 78269-6000
Emergency Phone Numbers General Assistance
24 Hour Emergency: 866-565-5220 General Assistance: 210-345-4593
Chemtrec Emergency: 800-424-9300
BRAND NAMES: Valero, Diamond Shamrock, Shamrock, Ultramar, Beacon, Total
Section 1. Chemical Product and Company Identification
: TRANSMIX
Common / Trade name
Synonym :
SYNONYMS/COMMON NAMES: This Material Safety Data Sheet applies to the listed products and synonym descriptions
for Hazard Communication purposes only. Technical specifications vary greatly depending on the product and are not
reflected in this document. Consult specification sheets for technical information. This product contains ingredients that
are considered to be hazardous as defined by the OSHA Hazard Communication Standard (29 CFR 1910.1200).
: This product is intended for use as a refinery feedstock, fuel, or for use in engineered
Material uses
processes. Use in other applications may result in higher exposures and require additional
controls, such as local exhaust ventilation and personal protective equipment.
: TransMix
MSDS #
: Mixture
CAS #
Section 2. Composition, information on ingredients
Name CAS number Concentration ( % )
Gasoline 86290-81-5 0 - 100
Diesel fuel 68476-34-6 0 - 100
Toluene 108-88-3 0 - 30
Hexane (Other Isomers) 96-14-0 5 - 25
Xylene (o,m,p isomers) 1330-20-7 0 - 25
Octane (All Isomers) 111-65-9 0 - 18.5
Methyl Tertiary Butyl Ether (MTBE) 1634-04-4 0 - 16
Ethanol 64-17-5 0 - 10
Tertiary Amyl Methyl Ether (TAME) 994-05-8 0-6
1,2,4-Trimethylbenzene 95-63-6 0-6
n-Heptane 142-82-5 1-5
Pentane 109-66-0 1-5
Cumene 98-82-8 0-5
Ethylbenzene 100-41-4 0-5
Benzene 71-43-2 0 - 4.9
Naphthalene 91-20-3 1-3
n-Nonane 111-84-2 1-3
n-Hexane 110-54-3 0-3
Cyclohexane 110-82-7 0-3
Continued on next page
TRANSMIX Page: 2/16
Section 3. Hazards Identification
Danger! Contains Benzene. Cancer Hazard. Can cause kidney, liver and blood disorders. May cause irritation to eyes, skin
and respiratory system. Avoid liquid, mist and vapor contact. Harmful or fatal if swallowed. Aspiration hazard; can enter lungs
and cause damage. May cause irritation or be harmful if inhaled or absorbed through the skin. Extremely flammable liquid.
Vapors may explode. Diesel Exhaust has been Reported to be an Occupational hazard due to NIOSH-reported potential
carcinogenic properties.
: Liquid.
Physical state
: Danger!
Emergency overview
CANCER HAZARD - CONTAINS MATERIAL WHICH CAN CAUSE CANCER.
HIGHLY FLAMMABLE LIQUID AND VAPOR.
HARMFUL IF SWALLOWED.
CONTAINS MATERIAL WHICH CAUSES DAMAGE TO THE FOLLOWING ORGANS:
BLOOD, KIDNEYS, LUNGS, REPRODUCTIVE SYSTEM, LIVER, PERIPHERAL
NERVOUS SYSTEM, GASTROINTESTINAL TRACT, RESPIRATORY TRACT, SKIN,
BONE MARROW, CENTRAL NERVOUS SYSTEM, EYE, LENS OR CORNEA.
VAPOR MAY CAUSE FLASH FIRE.
MAY BE HARMFUL IF ABSORBED THROUGH SKIN.
Do not ingest. Avoid prolonged contact with eyes, skin and clothing. Keep away from
heat, sparks and flame. Keep container closed. Use only with adequate ventilation.
Wash thoroughly after handling. Risk of cancer depends on duration and level of
exposure.
: Dermal contact. Eye contact. Inhalation. Ingestion.
Routes of entry
Potential acute health effects
: May cause severe irritation, redness, tearing, blurred vision and conjunctivitis.
Eyes
: Prolonged or repeated contact may cause moderate irritation, defatting (cracking),
Skin
redness, itching, inflammation, dermatitis and possible secondary infection. High
pressure skin injections are SERIOUS MEDICAL EMERGENCIES. Injury may not
appear serious at first. Within a few hours, tissues will become swollen, discolored and
extremely painful.
: Nasal and respiratory tract irritation, central nervous system effects including excitation,
Inhalation
euphoria, contracted eye pupils, dizziness, drowsiness, blurred vision, fatigue, nausea,
headache, loss of reflexes, tremors, convulsions, seizures, loss of consciousness, coma,
respiratory arrest and sudden death could occur as a result of long term and/or high
concentration exposure to vapors. May also cause anemia and irregular heart rhythm.
Repeated or prolonged exposure may cause behavioral changes.
: Toxic if swallowed. This product may be harmful or fatal if swallowed. This product may
Ingestion
cause nausea, vomiting, diarrhea and restlessness. DO NOT INDUCE VOMITING.
Aspiration into the lungs can cause severe chemical pneumonitis or pulmonary
edema/hemorrhage, which can be fatal. May cause gastrointestinal disturbances.
Symptoms may include irritation, depression, vomiting and diarrhea. May cause harmful
central nervous system effects, similar to those listed under "inhalation".
: Repeated exposure to a highly toxic material may produce general deterioration of health
Medical conditions
by an accumulation in one or many human organs. Preexisting eye, skin, heart, central
aggravated by over-
nervous system and respiratory disorders may be aggravated by exposure to this
exposure
product. Impaired kidney, liver and blood disorders may be aggravated by exposure to
this product.
: Nasal and respiratory tract irritation, central nervous system effects including excitation,
Over-exposure
euphoria, contracted eye pupils, dizziness, drowsiness, blurred vision, fatigue, nausea,
signs/symptoms
headache, loss of reflexes, tremors, convulsions, seizures, loss of consciousness, coma,
respiratory arrest or sudden death could occur as a result of long term and/or high
concentration exposure to vapors. May also cause anemia and irregular heart rhythm.
See toxicological information (section 11)
Continued on next page
TRANSMIX Page: 3/16
Section 4. First Aid Measures
: Flush immediately with large amounts of water for at least 15 minutes. Eyelids should be
Eye contact
held away from the eyeball to ensure thorough rinsing. Seek medical advice if pain or
redness continues.
: Remove contaminated clothing and shoes. Wash exposed area thoroughly with soap
Skin contact
and water. Remove contaminated clothing promptly and launder before reuse.
Contaminated leather goods should be discarded. If irritation persists or symptoms
described in the MSDS develop, seek medical attention. High pressure skin injections
are SERIOUS MEDICAL EMERGENCIES. Get immediate medical attention.
: If inhaled, remove to fresh air. If breathing is difficult, give oxygen. If not breathing, give
Inhalation
artificial respiration. Get medical attention.
: This product may be harmful or fatal if swallowed. This product may cause nausea,
Ingestion
vomiting, diarrhea and restlessness. DO NOT INDUCE VOMITING. Aspiration into the
lungs can cause severe chemical pneumonitis or pulmonary edema/hemorrhage, which
can be fatal. May cause gastrointestinal disturbances. Symptoms may include irritation,
depression, vomiting and diarrhea. May cause harmful central nervous system effects,
similar to those listed under "inhalation".
: In case of ingestion, gastric lavage with activated charcoal can be used promptly to
Notes to physician
prevent absorption. Consideration should be given to the use of an intratracheal tube, to
prevent aspiration. Irregular heart beat may occur, use of adrenalin is not advisable.
Individuals intoxicated by the product should be hospitalized immediately, with acute and
continuing attention to neurological and cardiopulmonary function. Positive pressure
ventilation may be necessary. After the initial episode, individuals should be monitored
for changes in blood variables and the delayed appearance of pulmonary edema and
chemical pneumonitis. Such patients should be monitored for several days or weeks for
delayed effects, including bone marrow toxicity, hepatic and renal impairment.
Individuals with chronic pulmonary disease will be more seriously impaired, and recovery
from inhalation exposure may be complicated. In case of skin injection, prompt
debridement of the wound is necessary to minimize necrosis and tissue loss.
Section 5. Fire Fighting Measures
Flammable.
Flammability of the product :
>260癈 (500癋)
Auto-ignition temperature :
Closed cup: -40癈 (-40癋).
Flash point :
Lower: 1.3% Upper: 7.1%
Flammable limits :
These products are carbon oxides (CO, CO2), nitrogen and sulfur oxides (NOX, SO X),
Products of combustion :
particulate matter, VOC's.
Fire hazards in the presence : Extremely flammable in the presence of open flames, sparks and static discharge.
of various substances
: Explosive in the presence of open flames, sparks and static discharge.
Explosion hazards in the
presence of various
substances
: Flammable Liquid. Use dry chemical, foam or carbon dioxide to extinguish the fire.
Fire-fighting media and
Consult foam manufacturer for appropriate media, application rates and water/foam
instructions
ratio. Subsurface application is only recommended where it is known that the fuel
contains less than 3% oxygenated blending components. Water can be used to cool
fire- exposed containers, structures and to protect personnel. If a leak or spill has not
ignited, ventilate area and use water spray to disperse gas or vapor and to protect
personnel attempting to stop a leak. Use water to flush spills away from sources of
ignition. Do not flush down public sewers.
Collect contaminated fire-fighting water separately. It must not enter the sewage system.
Dike area of fire to prevent runoff. Decontaminate emergency personnel and equipment
with soap and water.
Highly flammable liquid and vapor. Vapor may cause flash fire. Vapors may accumulate
in low or confined areas or travel a considerable distance to a source of ignition and
flash back. Runoff to sewer may create fire or explosion hazard.
Continued on next page
TRANSMIX Page: 4/16
: Fire-fighters should wear appropriate protective equipment and self-contained breathing
Special protective
apparatus (SCBA) with a full face-piece operated in positive pressure mode.
equipment for fire-fighters
: Dangerous when exposed to heat or flame. Vapors form flammable or explosive
Special remarks on fire
mixtures with air at room temperature. Vapor or gas may spread to distant ignition
hazards
sources (pilot lights, welding equipment, electrical equipment, etc.) and flash back.
Vapors may accumulate in low areas. Vapors may concentrate in confined areas.
Flowing product can be ignited by self generated static electricity. Use adequate bonding
and grounding to prevent static buildup. Runoff to sewer may cause fire or explosion
hazard. Containers may explode in heat of fire. Irritating or toxic substances may be
emitted upon thermal decomposition. For fires involving this material, do not enter any
enclosed or confined space without proper protective equipment, which may include
NIOSH approved self-contained breathing apparatus with full face mask. Clothing, rags
or similar organic material contaminated with this product and stored in a closed space
may undergo spontaneous combustion. Transfer to and from commonly bonded and
grounded containers.
: No additional remark.
Special remarks on
explosion hazards
Section 6. Accidental Release Measures
: Immediately contact emergency personnel. Eliminate all ignition sources. Keep
Personal precautions
unnecessary personnel away. Use suitable protective equipment (section 8). Do not
touch or walk through spilled material. Tanks, vessels or other confined spaces which
have contained product should be freed of vapors before entering. The container should
be checked to ensure a safe atmosphere before entry. Empty containers may contain
toxic,flammable/combustible or explosive residues or vapors. Do not cut, grind, drill,
weld or reuse empty containers that contained this product. Do not transfer this product
to another container unless the container receiving the product is labeled with proper
DOT shipping name, hazard class and other information that describes the product and
its hazards.
: Avoid dispersal of spilled material and runoff and contact with soil, waterways, drains
Environmental precautions
and sewers. Gasoline may contain oxygenated blend products (Ethanol, MTBE, etc.) that
are soluble in water and therefore precautions should be taken to protect surface and
groundwater sources from contamination. If facility or operation has an "oil or hazardous
substance contingency plan", activate its procedures. Stay upwind and away from spill.
Wear appropriate protective equipment including respiratory protection as conditions
warrant. Do not enter or stay in area unless monitoring indicates that it is safe to do so.
Isolate hazard area and restrict entry to emergency crew. Extremely flammable. Review
Fire Fighting Measures section before proceeding with clean up. Keep all sources of
ignition (flames, smoking, flares, etc.) and hot surfaces away from release. Contain spill
in smallest possible area. Recover as much product as possible (e.g., by vacuuming).
Stop leak if it can be done without risk. Use water spray to disperse vapors. Spilled
material may be absorbed by an appropriate absorbent, and then handled in accordance
with environmental regulations. Prevent spilled material from entering sewers, storm
drains, other unauthorized treatment or drainage systems and natural waterways.
Contact fire authorities and appropriate federal, state and local agencies. If spill of any
amount is made into or upon navigable waters, the contiguous zone, or adjoining
shorelines, contact the National Response Center at 800-424- 8802. For highway or
railway spills, contact Chemtrec at 800-424-9300.
: If emergency personnel are unavailable, contain spilled material. For small spills, add
Methods for cleaning up
absorbent (soil may be used in the absence of other suitable materials) and use a non-
sparking or explosion-proof means to transfer material to a sealable, appropriate
container for disposal. For large spills, dike spilled material or otherwise contain it to
ensure runoff does not reach a waterway. Place spilled material in an appropriate
container for disposal.
Continued on next page
TRANSMIX Page: 5/16
Section 7. Handling and Storage
: Do not ingest. Avoid prolonged contact with eyes, skin and clothing. Keep container
Handling
closed. Use only with adequate ventilation. Keep away from heat, sparks and flame. To
avoid fire or explosion, dissipate static electricity during transfer by grounding and
bonding containers and equipment before transferring material. Use explosion-proof
electrical (ventilating, lighting and material handling) equipment. Wash thoroughly after
handling. Use only in well ventilated locations. Keep away from heat, spark and flames.
In case of fire, use water spray, foam, dry chemical or carbon dioxide as described in the
Fire Fighting Measures section of the MSDS. Do not pressurize, cut, weld, braze,
solder, drill on or near this container. "Empty" container contains residue (liquid and/or
vapor) and may explode in heat of a fire.
Use good personal hygiene practices. After handling this product, wash hands before
eating, drinking, or using toilet facilities.
Keep out of reach of children. Failure to use caution may cause serious injury or illness.
Never siphon by mouth. For use as a motor fuel only. Do not use as a cleaning solvent
or for other non-motor fuel uses. To prevent ingestion and exposure - Do not siphon by
mouth to transfer product between containers. Use good personal hygiene practices.
After handling this product, wash hands before eating, drinking, or using toilet facilities.
: Store in tightly closed containers in cool, dry, isolated and well ventilated area away from
Storage
heat, sources of ignition and incompatible materials. Use non-sparking tools and
explosion proof equipment. Ground lines, containers, and other equipment used during
product transfer to reduce the possibility of a static induced spark. Do not "switch load"
because of possible accumulation of a static charge resulting in a source of ignition.
Use good personal hygiene practices.
Section 8. Exposure controls, personal protection
: Provide exhaust ventilation or other engineering controls to keep the airborne
Engineering controls
concentrations of vapors below their respective occupational exposure limits. Ensure
that eyewash stations and safety showers are close to the workstation location.
Personal protection
: Safety eyewear complying with an approved standard should be used when a risk
Eyes
assessment indicates this is necessary to avoid exposure to liquid splashes, mists or
dusts. Keep away from eyes. Eye contact can be avoided by wearing safety glasses or
chemical splash goggles.
: Personal protective equipment for the body should be selected based on the task being
Skin
performed and the risks involved and should be approved by a specialist before handling
this product. Keep away from skin. Skin contact can be minimized by wearing
protective gloves such as neoprene, nitrile-butadiene rubber, etc. and, where necessary,
impervious clothing and boots. Leather goods contaminated with this product should be
discarded. A source of clean water should be available in the work area for flushing
eyes and skin. Flame Retardant Clothing is recommended.
: Use a properly fitted, air-purifying or air-fed respirator complying with an approved
Respiratory
standard if a risk assessment indicates this is necessary.Respirator selection must be
based on known or anticipated exposure levels, the hazards of the product and the safe
working limits of the selected respirator. If workplace exposure limits for product or
components are exceeded, NIOSH approved equipment should be worn. Proper
respirator selection should be determined by adequately trained personnel, based on the
contaminants, the degree of potential exposure and published respiratory protection
factors. This equipment should be available for nonroutine and emergency use.
: Chemical-resistant, impervious gloves complying with an approved standard should be
Hands
worn at all times when handling chemical products if a risk assessment indicates this is
necessary.
: Consult your Supervisor or S.O.P. for special handling directions.
Personal protective
equipment (Pictograms)
Continued on next page
TRANSMIX Page: 6/16
: Splash goggles. Full suit. Vapor respirator. Boots. Gloves. Self-contained breathing
Personal protection in case
apparatus (SCBA) should be used to avoid inhalation of the product. Suggested
of a large spill
protective clothing might not be adequate. Consult a specialist before handling this
product.
Component Exposure limits
Gasoline ACGIH TLV (United States, 5/2004).
STEL: 500 ppm 15 minute(s). Form: All forms
TWA: 300 ppm 8 hour(s). Form: All forms
Diesel fuel ACGIH TLV (United States, 1/2004). Skin Notes: 2002 Adoption.
TWA: 100 mg/m?8 hour(s). Form: Total hydrocarbons
Toluene ACGIH TLV (United States, 5/2004). Skin Notes: 1996 Adoption
Refers to Appendix A -- Carcinogens.
TWA: 50 ppm 8 hour(s). Form: All forms
NIOSH REL (United States, 6/2001).
STEL: 150 ppm 15 minute(s). Form: All forms
TWA: 100 ppm 10 hour(s). Form: All forms
OSHA PEL Z2 (United States, 6/2002).
AMP: 500 ppm 10 minute(s). Form: All forms
CEIL: 300 ppm Form: All forms
TWA: 200 ppm 8 hour(s). Form: All forms
Hexane (Other Isomers) ACGIH TLV (United States, 9/2004).
STEL: 1000 ppm 15 minute(s). Form: All forms
TWA: 500 ppm 8 hour(s). Form: All forms
NIOSH REL (United States, 6/2001).
CEIL: 510 ppm 15 minute(s). Form: All forms
Xylene (o,m,p isomers) ACGIH TLV (United States, 5/2004).
STEL: 150 ppm 15 minute(s). Form: All forms
TWA: 100 ppm 8 hour(s). Form: All forms
OSHA PEL (United States, 6/1993).
TWA: 100 ppm 8 hour(s). Form: All forms
Octane (All Isomers) NIOSH REL (United States, 6/2001).
CEIL: 385 ppm 15 minute(s). Form: All forms
TWA: 75 ppm 10 hour(s). Form: All forms
OSHA PEL (United States, 6/1993).
TWA: 500 ppm 8 hour(s). Form: All forms
ACGIH TLV (United States, 3/2004). Notes: 1999 Adoption.
TWA: 300 ppm 8 hour(s). Form: All forms
Methyl Tertiary Butyl Ether (MTBE) ACGIH TLV (United States, 1/2004). Notes: 2002 Adoption.
TWA: 50 ppm 8 hour(s). Form: All forms
Ethanol ACGIH TLV (United States, 5/2004). Notes: 1996 Adoption Refers to
Appendix A -- Carcinogens.
TWA: 1000 ppm 8 hour(s). Form: All forms
NIOSH REL (United States, 6/2001).
TWA: 1000 ppm 10 hour(s). Form: All forms
OSHA PEL (United States, 6/1993).
TWA: 1000 ppm 8 hour(s). Form: All forms
Tertiary Amyl Methyl Ether (TAME) ACGIH TLV (United States, 1/2005). Notes: 2002 Adoption.
TWA: 20 ppm 8 hour(s). Form: All forms
1,2,4-Trimethylbenzene NIOSH REL (United States, 12/2001).
TWA: 25 ppm 10 hour(s). Form: All forms
ACGIH TLV (United States, 1/2005).
TWA: 25 ppm 8 hour(s). Form: All forms
n-Heptane ACGIH TLV (United States, 9/2004).
STEL: 500 ppm 15 minute(s). Form: All forms
TWA: 400 ppm 8 hour(s). Form: All forms
Continued on next page
TRANSMIX Page: 7/16
NIOSH REL (United States, 6/2001).
TWA: 350 mg/m?10 hour(s). Form: All forms
OSHA PEL (United States, 6/1993).
TWA: 500 ppm 8 hour(s). Form: All forms
Pentane ACGIH TLV (United States, 9/2004). Notes: 1998 Adoption.
TWA: 600 ppm 8 hour(s). Form: All forms
NIOSH REL (United States, 6/2001).
CEIL: 610 ppm 15 minute(s). Form: All forms
TWA: 120 ppm 10 hour(s). Form: All forms
OSHA PEL (United States, 6/1993).
TWA: 1000 ppm 8 hour(s). Form: All forms
Cumene ACGIH TLV (United States, 3/2004). Notes: 1999 Adoption.
TWA: 50 ppm 8 hour(s). Form: All forms
NIOSH REL (United States, 6/2001). Skin
TWA: 50 ppm 10 hour(s). Form: All forms
OSHA PEL (United States, 6/1993). Skin
TWA: 50 ppm 8 hour(s). Form: All forms
Ethylbenzene ACGIH TLV (United States, 1/2004).
STEL: 125 ppm 15 minute(s). Form: All forms
TWA: 100 ppm 8 hour(s). Form: All forms
NIOSH REL (United States, 6/2001).
STEL: 125 ppm 15 minute(s). Form: All forms
TWA: 100 ppm 10 hour(s). Form: All forms
OSHA PEL (United States, 6/1993).
TWA: 100 ppm 8 hour(s). Form: All forms
Benzene NIOSH REL (United States, 6/2001). Notes: See Appendix A - NIOSH
Potential Occupational Carcinogen
STEL: 1 ppm 15 minute(s). Form: All forms
TWA: 0.1 ppm 10 hour(s). Form: All forms
ACGIH TLV (United States, 1/2006). Skin
STEL: 2.5 ppm 15 minute(s). Form: All forms
TWA: 0.5 ppm 8 hour(s). Form: All forms
OSHA PEL (United States, 6/1993).
STEL: 5 ppm 15 minute(s). Form: All forms
TWA: 1 ppm 8 hour(s). Form: All forms
Naphthalene NIOSH REL (United States, 6/2001).
STEL: 15 ppm 15 minute(s). Form: All forms
TWA: 10 ppm 10 hour(s). Form: All forms
OSHA PEL (United States, 6/1993).
TWA: 10 ppm 8 hour(s). Form: All forms
ACGIH TLV (United States, 5/2004). Notes: 1996 Adoption Refers to
Appendix A -- Carcinogens.
STEL: 15 ppm 15 minute(s). Form: All forms
TWA: 10 ppm 8 hour(s). Form: All forms
n-Nonane NIOSH REL (United States, 6/2001).
TWA: 200 ppm 10 hour(s). Form: All forms
ACGIH TLV (United States, 9/2004).
TWA: 200 ppm 8 hour(s). Form: All forms
n-Hexane OSHA PEL (United States, 6/1993).
TWA: 500 ppm 8 hour(s). Form: All forms
ACGIH TLV (United States, 9/2004). Skin
TWA: 50 ppm 8 hour(s). Form: All forms
NIOSH REL (United States, 6/2001).
TWA: 50 ppm 10 hour(s). Form: All forms
Cyclohexane ACGIH TLV (United States, 1/2004).
TWA: 100 ppm 8 hour(s). Form: All forms
NIOSH REL (United States, 6/2001).
Continued on next page
TRANSMIX Page: 8/16
TWA: 300 ppm 10 hour(s). Form: All forms
OSHA PEL (United States, 6/1993).
TWA: 300 ppm 8 hour(s). Form: All forms
Consult local authorities for acceptable exposure limits.
Section 9. Physical and Chemical Properties
Liquid.
Physical state :
Light Straw to Red Clear Liquid
Color :
Hydrocarbon. [Strong]
Odor :
26.7 to 226.7癈 (80.1 to 440.1癋)
Boiling point :
0.66 to 0.75 (Water = 1) (@ 60 oF)
Specific gravity :
60.8 to 101.3 kPa (456 to 760 mm Hg) (at 20癈)
Vapor pressure :
3 to 4 (Air = 1)
Vapor density :
Essentially 100%
Volatility :
10 to 11 compared with Butyl acetate.
Evaporation rate :
Very slightly soluble in the following materials: cold water, hot water.
Solubility :
Section 10. Stability and reactivity data
: The product is stable.
Stability and reactivity
: Reactive with oxidizing agents, reducing agents, acids, alkalis.
Incompatibility with various
substances
: These products are carbon oxides (CO, CO2), nitrogen and sulfur oxides (NOX, SO X),
Hazardous decomposition
particulate matter, VOC's.
products
: Will not occur.
Hazardous polymerization
Section 11. Toxicological Information
Toxicity data
BENZENE is considered to be a carcinogen to humans, and may cause adverse health effects following exposure via inhalation, ingestion or dermal or
eye contact. Acute inhalation of benzene by rats, mice or rabbits caused narcosis, spontaneous heart contractions (ventricular fibrillation) and death due to
respiratory paralysis. Subchronic inhalation of benzene by rats produced decreased white blood cell counts, decreased bone marrow cell activity,
increased red blood cell activity and cataracts. In rats, chronic inhalation or oral administration of benzene produced cancers of the liver, mouth and
Zymbal gland. Acute inhalation exposure of benzene in humans has caused nerve inflammation (polyneuritis), central nervous system depression and
cardiac sensitization. Chronic exposure to benzene has produced anorexia and irreversible injury to the blood forming organs. Potential
effects include aplastic anemia and leukemia. It has a caused fetal defects in tests on laboratory animals.
CUMENE can affect the body if it is it inhaled, swallowed or comes in contact with the eyes or skin. The main toxic effect is irritation of the eyes, skin and
upper respiratory tract. Narcosis has been reported to occur in animals on high exposure. There are no reports of systemic effects in man as a result of
industrial exposure. Chronic exposure of rats above 500 ppm causes congestion of lungs, liver and kidneys, but no bone marrow changes.
CYCLOHEXANE can affect the body if it is inhaled, swallowed, or comes in contact with the eyes or skin. It is primarily a local irritant and central nervous
system depressant. The depressant effect is from exposure to concentrations above 12,000 ppm, while prolonged or repeated exposure to concentrations
above 300 ppm produces a mild irritation of the eyes and upper respiratory tract.
ETHANOL is rapidly absorbed through the gastrointestinal tract and normally metabolized and excreted in a relatively few hours. Only in very unusual
work situations could the inhalation of ethanol vapors result in symptoms of alcohol intoxication. Can be fatal or cause blindness if swallowed in extreme
quantities. Inhalation or ingestion can cause headache, nausea, dizziness or narcosis. Chronic overexposure (inhalation or ingestion) can cause damage
Continued on next page
TRANSMIX Page: 9/16
to the gastrointestinal tract, liver, kidneys and cardiovascular system. Prolonged contact causes irritation to skin and eyes. Medical conditions aggravated
by exposure include kidney, liver, heart and GI conditions. This material is not listed as a cancer causing agent but is suspected of being a promoter.
ETHYLBENZENE can affect the body if it is inhaled, swallowed or comes in contact with the eyes or skin. It is primarily an irritant of skin, and to some
degree, of eyes and upper respiratory tract. Systemic absorption causes depression of the central nervous system with narcosis at very high
concentrations. On the eyes and nose, the vapor at 5000 ppm causes intolerable irritation, eye irritation and lacrimation are immediate and severe at 2000
ppm, irritation and tearing occur at 1000 ppm although tolerance develops rapidly, and the vapor is a transient irritant on human eyes at 200 ppm.
Aspiration of small amounts causes extensive edema and hemorrhage of lung tissue. A draft report on a study conducted by the National Toxicology
program states that lifetime inhalation exposure of rats and mice to concentrations of ethylbenzene(750 ppm) resulted in increases in certain types of
cancer, including kidney tumors in rats and lung and liver tumors in mice. These effects were not observed in animals exposed to lower concentrations of
ethlybenzene (75 ppm or 250 ppm). The draft report does not address the relevance of these results to humans.
GASOLINE contains benzene, as well as n-hexane, other aromatics and certain olefins. Gasoline generally acts as an anesthetic and mucous membrane
irritant. Inhalation is the most important route of occupational entry. Eye and throat irritation occur in several hours at exposures of 160 to 270 ppm, eye,
nose and throat irritation and dizziness occurs at exposures of 500 to 900 ppm in one hour, mild anesthesia occurs in 30 minutes at exposures of 2000
ppm. The threshold for immediate mild toxic effect if 900 to 1000 ppm. There are reports of toxic neuritis after exposure to gasoline. Repeated exposure
of laboratory animals to high concentrations of gasoline vapors has caused kidney damage and cancer in rats and cancer in mice. Gasoline was evaluated
for genetic activity in assays using microbial cells, cultured mammalian cells and rat bone marrow cells. The results were all negative so gasoline was
considered nonmutagenic under these conditions. Overexposure to this product or its components has been suggested as a cause of liver abnormalities
in laboratory animals and humans. Lifetime studies by the American Petroleum Institute have shown that kidney damage and kidney cancer can occur in
male rats after prolonged inhalation exposures at elevated concentrations of total gasoline. Kidneys of mice and female rats were unaffected. The U.S.
EPA Risk Assessment Forum has concluded that the male rat kidney tumor results are not relevant for humans. Total gasoline exposure also produced
liver tumors in female mice only. The implication of these data for humans has not neen determined.
HEPTANE can affect the body if it is inhaled, comes in contact with the eyes or skin, or is swallowed. Heptane vapor is a narcotic. Concentrations of
10,000 to 15,000 ppm produced narcosis in mice within 30 to 60 minutes, while 15,000 to 20,000 ppm caused convulsions and death. At 48,000 ppm,
respiratory arrest was produced in mice in 3 to 4 minutes from the start of exposure. Human subjects exposed to 1,000 ppm for 6 minutes, or to 2,000
ppm for 4 minutes, reported slight vertigo. At 5,000 ppm for 4 minutes, there was marked vertigo, inability to walk a straight line, hilarity, and
incoordination, but no complaints of eye and upper respiratory tract or mucous membrane irritation. A 15-minute exposure at 5,000 ppm produced in some
subjects a state of stupor lasting for 30 minutes after exposure. These subjects also reported loss of appetite, slight nausea, and a taste resembling
gasoline for several hours after exposure. Although chronic nervous system affects have not been attributed to heptane, polyneuritis has been reported
following prolonged exposure to a petroleum fraction with boiling range between 70癈 and 100?C, and this fraction would normally contain various
isomers of heptane as major ingredients.
n-HEXANE can affect the body if it is inhaled, comes in contact with the eyes or skin, or is swallowed. Hexane vapor is a narcotic and a mild upper
respiratory irritant. Polyneuropathy (peripheral nerve damage) has been reported to occur in workers exposed to hexane vapors, characterized by
progressive weakness and numbness in the extremities, loss of deep tendon reflexes and reduction of motor nerve conduction velocity. Recovery ranges
from no recovery to complete recovery depending upon the duration of exposure and severity of nerve damage. Concentrations of 30,000 ppm produced
narcosis in mice within 30 to 60 minutes, convulsions and death occurred at 35,000 to 40,000 ppm, and at 64,000 ppm respiratory arrest was produced in
2.5 to 4.5 minutes from the start of exposure. Concentrations up to 8000 ppm produced no anesthesia. In human subjects, 2000 ppm for 10 minutes
produced no effects, but 5000 ppm resulted in dizziness and a sensation of giddiness. Other investigators reported slight nausea, headache and irritation
of the eyes and throat at 1400 to 1500 ppm. In industrial practice, mild narcotic symptoms such as dizziness have been observed when concentrations
exceeded 1000 ppm, but not below 500 ppm.
MTBE is a mild irritant to the eye. An increase in anesthesia with increasing concentrations was observed during a rat exposure study. Controlled human
exposure to MTBE in air under relatively temperate conditions does not cause increased symptoms or measurable responses (irritation, behavioral
changes) in healthy adult subjects. Although MTBE and TBA were detectable in the blood of subjects in clinical studies, no increase in symptoms
occurred. A tentative review of the carcinogenicity (i.e., a tentative C classification). A sensitivity analysis of cancer risk indices also suggests that, if
MTBE is carcinogenic, its potency is not likely to be greater than that already assigned to gasoline itself, which currently has a hazard classification of
"probable" human carcinogen.
OCTANE can affect the body if it is inhaled, comes in contact with the skin or eyes or is swallowed. Octane vapor is a mild narcotic and mucous membrane
irritant. Concentrations of 6600 to 13,700 ppm produced narcosis in mice in 30 to 90 minutes, the fatal concentration for animals is near 13,500 ppm. No
chronic systemic effects have been reported in humans.
PENTANE can affect the body if it is inhaled, comes in contact with the eyes or skin, or is swallowed. The chief effects of inhalation are narcosis and
irritation of the respiratory passages. Exposures of 90,000 to 120,000 ppm resulted in narcosis in animals in 5 to 6 minutes, 130,000 ppm was fatal with
respiratory arrest occurring within 5 minutes of exposure. Pentane injected subcutaneously in rats produced temporary impairment of liver function and
moderate neutropenia. While other aliphatic hydrocarbons produce drowsiness and mild irritation of the eyes and nose in human subjects, no symptoms
resulted from exposure to pentane vapor for 10 minutes at 5000 ppm. Chronic exposure to high concentrations may lead to polyneuropathy (peripheral
nerve damage), characterized by progressive weakness and numbness in the extremities, loss of deep tendon reflexes and reduction of motor nerve
conduction velocity.
TOLUENE can affect the body if it is inhaled, comes in contact with the eyes or skin or it is swallowed. It may also enter the body through the skin. Toluene
vapors cause narcosis. Controlled exposures of human subjects to 200 ppm for 8 hours produced mild fatigue, weakness, confusion, lacrimation and
paresthesia. At 600 ppm for 8 hours, there was euphoria, headache, dizziness, dilated pupils and nausea. At 800 ppm for 8 hours, symptoms were more
pronounced, and after effects included nervousness, muscular fatigue and insomnia persisting for several days. In workers exposed for many years to
concentrations in the range of 80 to 300 ppm, there was no clinical or laboratory evidence of altered liver function. Toluene exposure does not result in the
same chronic injury to bone marrow caused by benzene. Liquid splashed in the eyes of workers has caused transient corneal damage and conjunctival
irritation, complete recovery occurred within 48 hours. Animal studies have shown that inhalation of high levels of toluene produced cardiac sensitization.
Such sensitization may cause fatal changes in heart rhythms. This later effect was shown to be enhanced by hypoxia or the injection of adrenalin-like
agents. Workers exposed at less than 200 ppm have complained of headache, lassitude and nausea, but physical findings were essentially negative. At
concentrations between 200 and 500 ppm, impairment of coordination, momentary loss of memory and anorexia were present. Between 500 and 1500
ppm, palpitation, extreme weakness, pronounced loss of coordination and impairment of reaction time were noted. The red cell count fell in many
instances and there were cases of aplastic anemia in which recovery followed intensive hospital treatment (although some of the effects may have been
due to benzene impurity). Toluene has been reported to decrease immunological responses and cause recordable hearing loss in test animals. Damages
genetic material in mammalian test systems. May cause adverse reproductive effects based on animal testing.
TRIMETHYL BENZENE (PSEUDOCUMENE) can affect the body if it is inhaled, comes in contact with the eyes or skin or it is swallowed. It may also enter
the body through the skin. The liquid is a primary skin irritant, but system intoxication due to absorption through the skin is not probable. High
Continued on next page
TRANSMIX Page: 10/16
concentrations of vapors (5000 to 9000 ppm) caused central nervous system depression. Pseudocumene may cause nervousness, tension, anxiety, and
asthmatic bronchitis. In addition, the peripheral blood showed a tendency to hypochromic anemia and a deviation from the normal in the coagulability of
the blood.
XYLENE can affect the body if it is inhaled, comes in contact with the eyes or skin or it is swallowed. It may also enter the body through the skin. Xylene
vapor irritates the eyes, mucous membranes and skin. At high concentrations it causes narcosis. In animals, xylene causes blood changes reflecting mild
toxicity to the hematopoietic system. Laboratory animals exposed by various routes to high does of xylene showed evidence of effects in the liver, kidneys,
lungs, spleen, heart and adrenals. Rats exposed to xylene vapor during pregnancy showed embryo/fetotoxic effects. Mice exposed orally to doses
producing maternal toxicity also showed embryo or fetotoxic effects. Laboratory rats exposed to high concentrations of toluene experienced recordable
hearing loss. In humans, exposure to high concentrations can cause dizziness, excitement, drowsiness, incoordination and a staggering gait. Workers
exposed to concentrations above 200 ppm complain of anorexia, nausea, vomiting and abdominal pain. Brief exposures of humans to 200 ppm caused
irritation of the eyes, nose and throat. There are reports of reversible corneal vacuolation in workers exposed to xylene, or to xylene plus other volatile
solvents.
HEXANE ISOMERS are three times as toxic to mice as is pentane. Narcosis was produced in mice within 30-60 minutes at concentrations of 30,000 ppm.
In man, concentrations for 10 minutes at 2000 ppm produced no effects, but 5000 ppm caused dizziness and a sense of giddiness. Concentrations of
1400-1500 ppm produced slight nausea, headache, eye, and throat irritation.
NAPHTHALENE can affect the body if it is inhaled, comes into contact with the eyes or the skin or if it is swallowed. Naphthalene vapor causes hemolysis
and eye irritation, and may cause cataracts. Severe intoxication from ingestion of the solid results in characteristic manifestations of marked intravascular
hemolysis and its consequences, including potentially fatal hyperkalemia. Initial symptoms include eye irritation, headache, confusion, excitement,
malaise, profuse sweating, nausea, vomiting, abdominal pain, and irritation of the bladder. There may be progression to jaundice, hematuria,
hemoglobinuria, renal tubular blockage, and acute renal shutdown. Hematologic features include red cell fragmentation, icterus, severe anemia with
nucleated red cells, leukocytosis, and dramatic decreases in hemoglobin, hematocrit and red cell count; sometimes there is formation of Heinz bodies and
methemoglobin. Individuals with a deficiency of glucose-6-phosphate dehydrogenase in erythrocytes may be more susceptible to hemolysis by
naphthalene. Cataracts and ocular irritation have been produced experimentally in animals and have been described in humans. Of 21 workers exposed
to high concentrations of fume or vapor for 5 years, 8 had peripheral lens opacities; in other studies, no abnormalities of the eyes have been detected in
workers exposed to naphthalene for several years. The vapor causes eye irritation at 15 ppm. Eye contact with the solid may result in conjunctivitis,
superficial injury to the cornea, chorioretinitis, scotoma, and diminished visual acuity. Naphthalene on the skin may cause hypersensitivity dermatitis,
chronic dermatitis is rare.
NONANE causes a four hour LC50 in rats at concentrations of 3200 ppm, or at about the same level as VM&P Naphtha. This level is markedly lower than
the lethal concentrations reported in earlier mice studies involving octane (13,500 ppm) and heptane (16,000 ppm), supporting the lower limit for nonane.
DIESEL EXHAUST FUMES have been reported to be a potential occupational carcinogen in humans by NIOSH Current Intelligence Bulletin 50.
Test
Ingredient name Result Route Species
Toluene LD50 636 mg/kg Oral Rat
LDLo 50 mg/kg Oral human
Xylene (o,m,p isomers) LD50 4300 mg/kg Oral Rat
LD50 2119 mg/kg Oral Mouse
LD50 4300 mg/kg Oral Mammal
LD50 >1700 mg/kg Dermal Rabbit
LDLo 50 mg/kg Oral human
Ethanol LD50 7060 mg/kg Oral Rat
LD50 6300 mg/kg Oral Rabbit
LD50 3450 mg/kg Oral Mouse
LDLo 1400 mg/kg Oral human
LDLo 5500 mg/kg Oral Dog
Tertiary Amyl Methyl Ether LD50 1602 mg/kg Oral Rat
(TAME)
Pentane LD50 400 mg/kg Oral Rat
Cumene LD50 1400 mg/kg Oral Rat
LD50 12750 mg/kg Oral Mouse
Ethylbenzene LD50 3500 mg/kg Oral Rat
Benzene LD50 930 mg/kg Oral Rat
LD50 4700 mg/kg Oral Mouse
LD50 5700 mg/kg Oral Mammal
LD50 48 mg/kg Dermal Mouse
LDLo 50 mg/kg Oral man
Cyclohexane LD50 12705 mg/kg Oral Rat
LD50 813 mg/kg Oral Mouse
LDLo 5500 mg/kg Oral Rabbit
Continued on next page
TRANSMIX Page: 11/16
: CARCINOGENIC EFFECTS: Classified A3 (Proven for animals.) by ACGIH [Gasoline].
Chronic effects on humans
Classified A4 (Not classifiable for humans or animals.) by ACGIH, 3 (Not classifiable for
humans.) by IARC [Toluene]. Classified A4 (Not classifiable for humans or animals.) by
ACGIH, 3 (Not classifiable for humans.) by IARC [Xylene (o,m,p isomers)]. Classified A3
(Proven for animals.) by ACGIH [Methyl Tertiary Butyl Ether (MTBE)]. Classified 3 (Not
classifiable for humans.) by IARC [Methyl Tertiary Butyl Ether (MTBE)]. Classified A4
(Not classifiable for humans or animals.) by ACGIH [Ethanol]. Classified A3 (Proven for
animals.) by ACGIH, 2B (Possible for humans.) by IARC [Ethylbenzene]. Classified A1
(Confirmed for humans.) by ACGIH, 1 (Proven for humans.) by IARC, 1 (Known to be
human carcinogens.) by NTP, + (Proven.) by OSHA, + (Proven.) by NIOSH [Benzene].
A3 (Proven for animals.) by ACGIH, 3 (Possible for humans.) by European Union
[Diesel fuel]. Classified 3 (Not classifiable for humans.) by IARC [Diesel fuel]. Classified
2B (Possible for humans.) by IARC [Naphthalene]. Classified A4 (Not classifiable for
humans or animals.) by ACGIH [Naphthalene]. Contains material which causes damage
to the following organs: blood, kidneys, lungs, the reproductive system, liver, peripheral
nervous system, gastrointestinal tract, upper respiratory tract, skin, bone marrow, central
nervous system (CNS), eye, lens or cornea.
: Extremely hazardous by the following route of exposure: of ingestion.
Other toxic effects on
Very hazardous by the following route of exposure: of eye contact (irritant), .
humans
Hazardous by the following route of exposure: of skin contact (irritant).
Slightly hazardous by the following route of exposure: of inhalation (lung irritant).
: No additional remark.
Special remarks on toxicity
to animals
: No additional remark.
Special remarks on chronic
effects on humans
: No additional remark.
Special remarks on other
toxic effects on humans
Specific effects
: Contains material which can cause cancer.. Risk of cancer depends on duration and
Carcinogenic effects
level of exposure.
: Contains material which causes damage to the following organs: blood, kidneys, lungs,
Target organs
the reproductive system, liver, peripheral nervous system, gastrointestinal tract, upper
respiratory tract, skin, bone marrow, central nervous system (CNS), eye, lens or cornea.
Section 12. Ecological Information
Ecotoxicity data
Species
Ingredient name Period Result
Toluene Daphnia magna (EC50) 48 hour(s) 6 mg/l
Daphnia magna (EC50) 48 hour(s) 6.56 mg/l
Oncorhynchus mykiss (EC50) 48 hour(s) 6.78 mg/l
Oncorhynchus mykiss (LC50) 96 hour(s) 5.8 mg/l
Oncorhynchus mykiss (LC50) 96 hour(s) 6.78 mg/l
Pimephales promelas (LC50) 96 hour(s) 12.6 mg/l
Xylene (o,m,p isomers) Oncorhynchus mykiss (LC50) 96 hour(s) 3.3 mg/l
Oncorhynchus mykiss (LC50) 96 hour(s) 8.2 mg/l
Lepomis macrochirus (LC50) 96 hour(s) 8.6 mg/l
Lepomis macrochirus (LC50) 96 hour(s) 12 mg/l
Lepomis macrochirus (LC50) 96 hour(s) 13.3 mg/l
Pimephales promelas (LC50) 96 hour(s) 13.4 mg/l
Methyl Tertiary Butyl Ether (MTBE) Pimephales promelas (LC50) 96 hour(s) 672 mg/l
Ethanol Daphnia magna (EC50) 48 hour(s) 2 mg/l
Daphnia magna (EC50) 48 hour(s) 9.3 mg/l
Daphnia magna (EC50) 48 hour(s) >100 mg/l
Pimephales promelas (LC50) 96 hour(s) >100 mg/l
Daphnia magna (LC50) 96 hour(s) >100 mg/l
Oncorhynchus mykiss (LC50) 96 hour(s) 13000 mg/l
1,2,4-Trimethylbenzene Pimephales promelas (LC50) 96 hour(s) 7.72 mg/l
Continued on next page
TRANSMIX Page: 12/16
Cumene Daphnia magna (EC50) 48 hour(s) 10.6 mg/l
Daphnia magna (EC50) 48 hour(s) 11.2 mg/l
Oncorhynchus mykiss (LC50) 96 hour(s) 2.7 mg/l
Poecilia reticulata (LC50) 96 hour(s) 5.1 mg/l
Pimephales promelas (LC50) 96 hour(s) 6.32 mg/l
Ethylbenzene Daphnia magna (EC50) 48 hour(s) 2.93 mg/l
Daphnia magna (EC50) 48 hour(s) 2.97 mg/l
Selenastrum capricornutum 48 hour(s) 7.2 mg/l
(EC50)
Oncorhynchus mykiss (LC50) 96 hour(s) 4.2 mg/l
Pimephales promelas (LC50) 96 hour(s) 9.09 mg/l
Poecilia reticulata (LC50) 96 hour(s) 9.6 mg/l
Benzene Daphnia magna (EC50) 48 hour(s) 9.23 mg/l
Daphnia magna (EC50) 48 hour(s) 10 mg/l
Daphnia magna (EC50) 48 hour(s) 11.73 mg/l
Oncorhynchus mykiss (LC50) 96 hour(s) 5.3 mg/l
Oncorhynchus mykiss (LC50) 96 hour(s) 5.9 mg/l
Oncorhynchus mykiss (LC50) 96 hour(s) 9.2 mg/l
n-Hexane Pimephales promelas (LC50) 96 hour(s) 2.5 mg/l
Cyclohexane Pimephales promelas (LC50) 96 hour(s) 4.53 mg/l
Pimephales promelas (LC50) 96 hour(s) 32.71 mg/l
Lepomis macrochirus (LC50) 96 hour(s) 34.72 mg/l
Pimephales promelas (LC50) 96 hour(s) 42.33 mg/l
Poecilia reticulata (LC50) 96 hour(s) 57.68 mg/l
Pimephales promelas (LC50) 96 hour(s) 93 mg/l
: Decomposition products may include the following materials: carbon oxides (CO, CO2)
Products of degradation
and water.
: The products of biodegradation are as toxic as the original product.
Toxicity of the products of
biodegradation
: No additional remark.
Special remarks on the
products of biodegradation
Section 13. Disposal Considerations
: The generation of waste should be avoided or minimized wherever possible. Avoid
Waste disposal
dispersal of spilled material and runoff and contact with soil, waterways, drains and
sewers. Disposal of this product, solutions and any by-products should at all times
comply with the requirements of environmental protection and waste disposal legislation
and any regional local authority requirements.
Consult your local or regional authorities.
Section 14. Transport Information
Regulatory UN number Proper shipping Class Packing group Label Additional
information name information
1268 PETROLEUM 3 I Not available.
DOT Classification
DISTILLATES, N.O.S. FLAMMABLE LIQUID
3
1268 PETROLEUM 3 I Not available.
TDG Classification
DISTILLATES, N.O.S.
3
Continued on next page
TRANSMIX Page: 13/16
Section 15. Regulatory Information
United States
: TSCA 4(a) final test rules: Hexane (Other Isomers); n-Heptane; Pentane; n-Hexane;
U.S. Federal regulations
Naphthalene; n-Nonane
TSCA 8(a) PAIR: Tertiary Amyl Methyl Ether (TAME); n-Heptane; Pentane;
Naphthalene; n-Nonane
United States inventory (TSCA 8b): All material are listed
TSCA 12(b) one-time export: n-Heptane; Pentane; Naphthalene; n-Nonane
TSCA 12(b) annual export notification: Hexane (Other Isomers); n-Hexane
SARA 302/304/311/312 extremely hazardous substances: No products were found.
SARA 302/304 emergency planning and notification: No products were found.
SARA 302/304/311/312 hazardous chemicals: Toluene; Hexane (Other Isomers);
Xylene (o,m,p isomers); Octane (All Isomers); Methyl Tertiary Butyl Ether (MTBE);
Ethanol; Tertiary Amyl Methyl Ether (TAME); 1,2,4-Trimethylbenzene; n-Heptane;
Pentane; Cumene; Ethylbenzene; Benzene; n-Hexane; Cyclohexane; Naphthalene; n-
Nonane
SARA 311/312 MSDS distribution - chemical inventory - hazard identification:
Toluene: Fire hazard, Immediate (acute) health hazard, Delayed (chronic) health hazard;
Hexane (Other Isomers): Fire hazard, Immediate (acute) health hazard; Xylene (o,m,p
isomers): Fire hazard, Immediate (acute) health hazard, Delayed (chronic) health
hazard; Octane (All Isomers): Fire hazard; Methyl Tertiary Butyl Ether (MTBE): Fire
hazard; Ethanol: Fire hazard, Immediate (acute) health hazard, Delayed (chronic) health
hazard; Tertiary Amyl Methyl Ether (TAME): Fire hazard, Immediate (acute) health
hazard; 1,2,4-Trimethylbenzene: Fire hazard, Delayed (chronic) health hazard; n-
Heptane: Fire hazard; Pentane: Fire hazard, Immediate (acute) health hazard; Cumene:
Fire hazard, Immediate (acute) health hazard; Ethylbenzene: Fire hazard, Immediate
(acute) health hazard, Delayed (chronic) health hazard; Benzene: Fire hazard,
Immediate (acute) health hazard, Delayed (chronic) health hazard; n-Hexane: Fire
hazard, Immediate (acute) health hazard, Delayed (chronic) health hazard; Cyclohexane:
Fire hazard, Immediate (acute) health hazard, Delayed (chronic) health hazard;
Gasoline: Fire hazard, Immediate (acute) health hazard, Delayed (chronic) health
hazard; Naphthalene: Fire hazard, Immediate (acute) health hazard, Delayed (chronic)
health hazard; n-Nonane: Fire hazard, Immediate (acute) health hazard
Clean Water Act (CWA) 307: Toluene; Ethylbenzene; Benzene; Naphthalene
Clean Water Act (CWA) 311: Toluene; Xylene (o,m,p isomers); Ethylbenzene; Benzene;
Cyclohexane; Naphthalene
Clean Air Act (CAA) 112 accidental release prevention: Pentane
Clean Air Act (CAA) 112 regulated flammable substances: Pentane
Clean Air Act (CAA) 112 regulated toxic substances: No products were found.
SARA 313
Product name CAS number Concentration
: Toluene 108-88-3 0 - 30
Form R - Reporting
Xylene (o,m,p isomers) 1330-20-7 0 - 25
requirements
Methyl Tertiary Butyl Ether (MTBE) 1634-04-4 0 - 16
1,2,4-Trimethylbenzene 95-63-6 0-6
Cumene 98-82-8 0-5
Ethylbenzene 100-41-4 0-5
Benzene 71-43-2 0 - 4.9
Naphthalene 91-20-3 1-3
n-Hexane 110-54-3 0-3
Cyclohexane 110-82-7 0-3
: Toluene 108-88-3 0 - 30
Supplier notification
Xylene (o,m,p isomers) 1330-20-7 0 - 25
Methyl Tertiary Butyl Ether (MTBE) 1634-04-4 0 - 16
1,2,4-Trimethylbenzene 95-63-6 0-6
Cumene 98-82-8 0-5
Ethylbenzene 100-41-4 0-5
Benzene 71-43-2 0 - 4.9
Continued on next page
TRANSMIX Page: 14/16
Naphthalene 91-20-3 1-3
n-Hexane 110-54-3 0-3
Cyclohexane 110-82-7 0-3
SARA 313 notifications must not be detached from the MSDS and any copying and redistribution of the MSDS shall
include copying and redistribution of the notice attached to copies of the MSDS subsequently redistributed.
: Connecticut Carcinogen Reporting: None of the components are listed.
State regulations
Connecticut Hazardous Material Survey: None of the components are listed.
Florida substances: None of the components are listed.
Illinois Chemical Safety Act: None of the components are listed.
Illinois Toxic Substances Disclosure to Employee Act: None of the components are
listed.
Louisiana Reporting: None of the components are listed.
Louisiana Spill: None of the components are listed.
Massachusetts Spill: None of the components are listed.
Massachusetts Substances: The following components are listed: TOLUENE; 3-
METHYLPENTANE; XYLENE; OCTANE; METHYL TERT-BUTYL ETHER; ETHYL
ALCOHOL; PSEUDOCUMENE; HEPTANE (N-HEPTANE); PENTANE; CUMENE;
ETHYL BENZENE; BENZENE; NAPHTHALENE; NONANE; HEXANE;CYCLOHEXANE
Michigan Critical Material: None of the components are listed.
Minnesota Hazardous Substances: None of the components are listed.
New Jersey Hazardous Substances: The following components are listed: MOTOR
FUEL, n.o.s.; FUEL OIL; TOLUENE; XYLENES; OCTANE; METHYL-tert-BUTYL
ETHER; ETHYL ALCOHOL; PSEUDOCUMENE; n-HEPTANE; PENTANE; CUMENE;
ETHYL BENZENE; BENZENE; NAPHTHALENE; NONANE; n-
HEXANE;CYCLOHEXANE
New Jersey Spill: None of the components are listed.
New Jersey Toxic Catastrophe Prevention Act: None of the components are listed.
New York Acutely Hazardous Substances: The following components are listed:
Toluene; Xylene (mixed); Methyl tert-butyl ether; Benzene,1-methylethyl-; Ethylbenzene;
Benzene; Naphthalene; Hexane;Benzene, hexahydro-
New York Toxic Chemical Release Reporting: None of the components are listed.
Pennsylvania RTK Hazardous Substances: The following components are listed:
GASOLINE; BENZENE, METHYL-; PENTANE, 3-METHYL-; BENZENE, DIMETHYL-;
OCTANE; METHYL TERT-BUTYL ETHER; DENATURED ALCOHOL;
PSEUDOCUMENE; HEPTANE; PENTANE; BENZENE, (1-METHYLETHYL)-;
BENZENE, ETHYL-; BENZENE; NAPHTHALENE; NONANE;
HEXANE;CYCLOHEXANE
Rhode Island Hazardous Substances: None of the components are listed.
WARNING: This product contains a chemical or chemicals known to the state of
California to cause cancer, birth defects or other reproductive harm.: Toluene; Benzene
Naphthalene WARNING: This product contains a chemical or chemicals known to the
state of California to cause reproductive harm (male).: Benzene
California prop. 65 (no significant risk level): Benzene
California prop. 65 (Maximum Acceptable Dosage Level): Toluene; Benzene
WARNING: This product contains a chemical or chemicals known to the state of
California to cause birth defects or other reproductive harm.: Toluene; Benzene
WARNING: This product contains a chemical or chemicals known to the state of
California to cause cancer.: Benzene Naphthalene
Canada
: Class B-2: Flammable liquid
WHMIS (Canada)
Class D-2A: Material causing other toxic effects (Very toxic).
Class D-2B: Material causing other toxic effects (Toxic).
CEPA DSL: Toluene; Naphthalene; n-Nonane; Diesel fuel;Hexane (Other Isomers);
Xylene (o,m,p isomers); Octane (All Isomers); Methyl Tertiary Butyl Ether (MTBE);
Ethanol; Tertiary Amyl Methyl Ether (TAME); 1,2,4-Trimethylbenzene; n-Heptane;
Pentane; Cumene; Ethylbenzene; Benzene; n-Hexane; Cyclohexane; Trimethyl Benzene
(Pseudocumene); Gasoline
Continued on next page
TRANSMIX Page: 15/16
Section 16. Other Information
: CANCER HAZARD - CONTAINS MATERIAL WHICH CAN CAUSE CANCER.
Label requirements
HIGHLY FLAMMABLE LIQUID AND VAPOR.
HARMFUL IF SWALLOWED.
CONTAINS MATERIAL WHICH CAUSES DAMAGE TO THE FOLLOWING ORGANS:
BLOOD, KIDNEYS, LUNGS, REPRODUCTIVE SYSTEM, LIVER, PERIPHERAL
NERVOUS SYSTEM, GASTROINTESTINAL TRACT, RESPIRATORY TRACT, SKIN,
BONE MARROW, CENTRAL NERVOUS SYSTEM, EYE, LENS OR CORNEA.
VAPOR MAY CAUSE FLASH FIRE.
MAY BE HARMFUL IF ABSORBED THROUGH SKIN.
1
Hazardous Material : Health
Information System (U.S.A.)
3
Fire hazard
0
Physical Hazard
Personal
protection
National Fire Protection :
3 Flammability
Association (U.S.A.)
Health 1 0 Instability
Specific hazard
Date of printing : 9/20/2008.
: 9/20/2008.
Date of issue
:1
Version
Disclaimer
THIS MATERIAL SAFETY DATA SHEET ("MSDS") WAS PREPARED IN ACCORDANCE WITH 29 CFR 1910.1200 BY
VALERO MARKETING & SUPPLY CO., ("VALERO"). VALERO DOES NOT ASSUME ANY LIABILITY ARISING OUT OF
PRODUCT USE BY OTHERS. THE INFORMATION, RECOMMENDATIONS, AND SUGGESTIONS PRESENTED IN
THIS MSDS ARE BASED UPON TEST RESULTS AND DATA BELIEVED TO BE RELIABLE. THE END USER OF THE
PRODUCT HAS THE RESPONSIBILITY FOR EVALUATING THE ADEQUACY OF THE DATA UNDER THE CONDITIONS
OF USE, DETERMINING THE SAFETY, TOXICITY, AND SUITABILITY OF THE PRODUCT UNDER THESE
CONDITIONS, AND OBTAINING ADDITIONAL OR CLARIFYING INFORMATION WHERE UNCERTAINTY EXISTS. NO
GUARANTEE EXPRESSED OR IMPLIED IS MADE AS TO THE EFFECTS OF SUCH USE, THE RESULTS TO BE
OBTAINED, OR THE SAFETY AND TOXICITY OF THE PRODUCT IN ANY SPECIFIC APPLICATION. FURTHERMORE,
THE INFORMATION HEREIN IS NOT REPRESENTED AS ABSOLUTELY COMPLETE, SINCE IT IS NOT PRACTICABLE
TO PROVIDE ALL THE SCIENTIFIC AND STUDY INFORMATION IN THE FORMAT OF THIS DOCUMENT, PLUS
ADDITIONAL INFORMATION MAY BE NECESSARY UNDER EXCEPTIONAL CONDITIONS OF USE, OR BECAUSE OF
APPLICABLE LAWS OR GOVERNMENT REGULATIONS.
Definitions of Material Safety Data Sheet Terminology
GOVERNMENT AGENCIES AND PRIVATE ASSOCIATIONS
ACGIH - American Conference of Governmental Industrial Hygienists, (private association)
DOT - United States Department of Transportation
EPA - United States Environmental Protection Agency
IARC - International Agency for Research on Cancer, (private association)
NFPA - National Fire Protection Association, (private association)
MSHA - Mine Safety and Health Administration, U.S. Department of Labor
NIOSH - National Institute of Occupational Safety and Health, U.S. Department of Health and Human Services
NTP - National Toxicology Program, (private association)
OSHA - Occupational Safety and Health Administration, U.S. Department of Labor
WHMIS- Workplace Hazardous Material Information System
CSA- Canadian Standards Association
HAZARD AND EXPOSURE INFORMATION
Continued on next page
TRANSMIX Page: 16/16
Acute Hazard - An adverse health effect which occurs rapidly as a result of short term exposure.
CAS # - American Chemical Society's Chemical Abstract service registry number which identifies the product and/or
ingredients.
Ceiling - The concentration that should not be exceeded during any part of the working exposure
Chronic Hazard - An adverse health effect which generally occurs as a result of long term exposure or short term
exposure with delayed health effects and is of long duration
Fire Hazard - A material that poses a physical hazard by being flammable, combustible, phyrophoric or an oxidizer as
defined by 29 CFR 1910.1200
Hazard Class - DOT hazard classification
Hazardous Ingredients - Names of ingredients which have been identified as health hazards
IDLH- Immediately Dangerous to Life and Health, the airborne concentration below which a person can escape without
respiratory protection and exposure up to 30 minutes, and not suffer debilitating or irreversible health effects. Established
by NIOSH.
mg/m3 - Milligrams of contaminant per cubic meter of air, a mass to volume ratio
N/A - Not available or no relevant information found
NA - Not applicable
PEL - OSHA permissible exposure limit; an action level of one half this value may be applicable
ppm - Part per million (one volume of vapor or gas in one million volumes of air)
Pressure Hazard - A material that poses a physical hazard due to the potential of a sudden release of pressure such as
explosive or a compressed gas as defined by 29 CFR 1910.1200
Reactive Hazard - A material that poses a physical hazard due to the potential to become unstable reactive, water reactive
or that is an organic peroxide as defined by 29 CFR 1910.1200.
STEL - The ACGIH Short-Term Exposure Limit, a 15-minute Time-Weighted Average exposure which should not be
exceeded at any time during a workday, even if the 8-hour TWA is less than the TLV.
TLV - ACGIH Threshold Limit Value, represented herein as an 8-hour TWA concentration.
8-hour TWA - The time weighted average concentration for a normal 8-hour workday and a 40-hour workweek, to which
nearly all workers may be repeatedly exposed, day after day, without adverse effect.
LD50 ?Single dose of a substance that, when administered by a defined route in an animal assay, is expected to cause the
death of 50% of the defined animal population.
LC50 - The concentration of a substance in air that, when administered by means of inhalation over a specified length of
time in an animal assay, is expected to cause the death of 50% of a defined animal population.
|